Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GeneDx Holdings (WGSWW) Interest & Investment Income (2020 - 2025)

GeneDx Holdings has reported Interest & Investment Income over the past 6 years, most recently at -$520000.0 for Q4 2025.

  • Quarterly results put Interest & Investment Income at -$520000.0 for Q4 2025, up 25.5% from a year ago — trailing twelve months through Dec 2025 was -$2.5 million (up 16.26% YoY), and the annual figure for FY2025 was -$2.5 million, up 16.26%.
  • Interest & Investment Income for Q4 2025 was -$520000.0 at GeneDx Holdings, up from -$562000.0 in the prior quarter.
  • Over the last five years, Interest & Investment Income for WGSWW hit a ceiling of $1.1 million in Q4 2022 and a floor of -$978000.0 in Q4 2023.
  • Median Interest & Investment Income over the past 5 years was $15000.0 (2021), compared with a mean of -$53500.0.
  • Biggest five-year swings in Interest & Investment Income: skyrocketed 5063.64% in 2022 and later tumbled 186.09% in 2023.
  • GeneDx Holdings' Interest & Investment Income stood at $22000.0 in 2021, then skyrocketed by 5063.64% to $1.1 million in 2022, then tumbled by 186.09% to -$978000.0 in 2023, then grew by 28.63% to -$698000.0 in 2024, then increased by 25.5% to -$520000.0 in 2025.
  • The last three reported values for Interest & Investment Income were -$520000.0 (Q4 2025), -$562000.0 (Q3 2025), and -$817000.0 (Q2 2025) per Business Quant data.